A comprehensive developability panel for accelerating antibody development into the clinic with a selective and highly predictive set of assays
Irina Burnina
Meet Adimab at PEGS Europe 2026
Join the Adimab team at PEGS Europe to learn about new approaches to therapeutic antibody discovery and engineering, from developability profiling and off-target screening to next-generation T cell engagers.
November 16–19, 2026 | Lisbon Congress Center | Lisbon, Portugal
Advancing antibody discovery and engineering
We will be at PEGS Europe to share our latest work and connect with scientists and industry leaders across protein and antibody engineering.
Hear from Adimab scientists presenting new data on multispecific antibody developability and TCR-targeted T cell engagement, cnd connect with our team to discuss your antibody discovery and engineering programs.
Featured presentations
Keynote: Developability profiling, off-target screening, and CDR engineering to de-risk therapeutic antibodies
Presenter: Arvind Sivasubramanian, PhD | Director, Computational Biology & Platform Technologies, Adimab
Date & time: Wednesday, November 18 | 11:15
Track: Advancing Multispecific Antibodies and Combination Therapy to the Clinic
Learn how proteome-scale screening, off-target epitope mapping, and multidimensional CDR engineering can eliminate off-target binding while preserving affinity and improving biophysical developability.
Talk: TCR constant region-targeting VHH bispecifics: An NHP cross-reactive alternative to CD3 T cell engagers
Presenter:Michael B. Battles, PhD | Principal Scientist, Adimab
Date & time:Wednesday, November 18 | 19:00
Track: Advances in Immunoengineering
See how VHH bispecifics targeting the TCRα/β constant region interface support pan-αβ T cell redirection, TRBC1/TRBC2 coverage, and human-cynomolgus cross-reactivity.
Chaired session: Rational de novo design and library-based discovery
Chair: Aaron K. Sato, PhD | Chief Strategy Officer, Adimab
Date & time: Thursday, November 19 | 14:00
Track: Novel Peptide Drug Discovery: Discovery, Engineering and Design
Join a session on rational design and library-based approaches to protein and peptide discovery, including AI-enabled discovery, cyclic peptide engineering, and de novo protein design.
Posters
Visit our scientific posters and speak with the authors to learn more about exciting developments at Adimab.
Predicting biophysical properties of multispecific antibodies
Emily Radke
FAQs
What can I discuss with the Adimab team in Lisbon?
Bring your antibody discovery and engineering programs, including multispecifics, T cell engagers, and T cell receptor engineering. We're also happy to discuss partnership options and answer general scientific questions.
Can I request a meeting before the event?
Yes, you can use the form to share your contact details and what you'd like to discuss. That gives us the context to coordinate the right people and prepare for a focused conversation.